Differential Diagnosis of Pulmonic Stenosis by Means of Intracardiac Phonocardiography

Total Page:16

File Type:pdf, Size:1020Kb

Differential Diagnosis of Pulmonic Stenosis by Means of Intracardiac Phonocardiography Differential Diagnosis of Pulmonic Stenosis by Means of Intracardiac Phonocardiography Tadashi KAMBE, M.D., Tadayuki KATO, M.D., Norio HIBI, M.D., Yoichi FUKUI, M.D., Takemi ARAKAWA, M.D., Kinya NISHIMURA,M.D., Hiroshi TATEMATSU,M.D., Arata MIWA, M.D., Hisao TADA, M.D., and Nobuo SAKAMOTO,M.D. SUMMARY The purpose of the present paper is to describe the origin of the systolic murmur in pulmonic stenosis and to discuss the diagnostic pos- sibilities of intracardiac phonocardiography. Right heart catheterization was carried out with the aid of a double- lumen A.E.L. phonocatheter on 48 pulmonic stenosis patients with or without associated heart lesions. The diagnosis was confirmed by heart catheterization and angiocardiography in all cases and in 38 of them, by surgical intervention. Simultaneous phonocardiograms were recorded with intracardiac pressure tracings. In valvular pulmonic stenosis, the maximum ejection systolic murmur was localized in the pulmonary artery above the pulmonic valve and well transmitted to both right and left pulmonary arteries, the superior vena cava, and right and left atria. The maximal intensity of the ejection systolic murmur in infundibular stenosis was found in the outflow tract of right ventricle. The contractility of the infundibulum greatly contributes to the formation of the ejection systolic murmur in the outflow tract of right ventricle. In tetralogy of Fallot, the major systolic murmur is caused by the pulmonic stenosis, whereas the high ventricular septal defect is not responsible for it. In pulmonary branch stenosis, the sys- tolic murmur was recorded distally to the site of stenosis. Intracardiac phonocardiography has proved useful for the dif- ferential diagnosis of various types of pulmonic stenosis. Additional Indexing Words: Right heart catheterization Pulmonic valvular stenosis Infundibular stenosis Pulmonary branch stenosis NTRACARDIAC phonocardiography, introduced by Yamakawa in 1953,1) was a breakthrough in the realm of clinical phonocardiography. Since the advent of this method, it has served as a useful tool for differential diagno- From the Third Department of Internal Medicine, Nagoya University, School of Medicine , Tsurumai-cho 65, Showa-ku, Nagoya 466, Japan. Received for publication December 8, 1975. 691 Jap.N Heart J. 692 KAMBE, ET AL. ovember, 1976 sis, thus contributing to the analysis of the origin of the cardiac murmurs and sounds in heart chambers or great vessels. In general, conventional external phonocardiography is non-invasive and simple, but may not always correctly reflect the acoustic events occurring in the cardiac chambers or great vessels. In contrast, intracardiac phono- cardiography can localize the origin of cardiac murmurs or sounds in a wide variety of cardiovascular diseases and may detect the result of small eddies that are usually inaudible on the chest surface. Since the introduction of intracardiac phonocardiography, many pub- lications2)-10) have discussed the origin of the systolic murmurs in pulmonic stenosis. Recently, Lequime et al11) reported on the origin of systolic mur- murs in pulmonic stenoses of different types, comparing intracardiac phono- cardiography with angiocardiography. The purpose of the present study is to describe the origin and transmission of the systolic murmurs in pulmonic stenosis of various types, and to discuss the diagnostic possibilities of intracardiac phonocardiography. MATERIAL AND METHODS Right heart catheterization using intracardiac phonocardiography was carried out on 48 pulmonic stenosis patients with or without associated cardiac anomalies. The age ranged from 3 to 41 years. The cardiac diagnosis of the subjects, as shwon in Table I, was confirmed by heart catheterization and angiocardiography. Of Table I. Materials Abbreviations: PS: pulmonic stenosis, ASD: atrial septal defect, VSD: ventricular septal defect, PLSVC: persistent left superior vena cava, PAPVD: partial anomalous pulmonary venous drainage, T/F: tetralogy of Fallot, Pul.: pulmonic. * The manufacturer of the phonocatheter is A .E.L. (American Electric Laboratories Inc.), P.O. Box 552, Lansdale, PA. 19446, U.S.A. Vol.17 No.6 INTRACARDIAC PHONOCARDIOGRAPHY 693 the 48 patients, the diagnosis of 38 was eventually verified by surgical intervention. A double-lumen phonocatheter of A.E.L.,* with barium titanate on the tip, was introduced into the left axillary vein and advanced to the pulmonary artery via superior vena cava, right atrium and ventricle. All procedures of heart catheteriza- tion were performed in the sedated and postabsorptive state after informed consent was obtained. In the majority of cases, a simultaneous recording of intracardiac and external phonocardiograms was made in conjunction with intracardiac pres- sure tracing with the aid of a polygraph (Fukuda-denshi EMR-100R) and a photo- graphic recorder (Sanei-sokki 100A). A pressure transducer TM-1 was used for the pressure tracing and a contact microphone (Fukuda-denshi MA-250 or PM-1) was applied to the chest surface where the maximum murmur was audible. Paper speed was 100mm/sec in the majority of cases, and intracardiac murmurs were usually investigated in the pulmonary artery of both sides from the main trunk to the periphery, right ventricle, right atrium and superior vena cava. In 9 cases the left atrium was entered and a systolic murmur was recorded. During the recording of systolic murmurs, the phonocatheter was manipulated with great care and the withdrawal from the pulmonary artery into the right ventricle was repeated very slowlywith caution, since the outflow tract may produce artificial extrasounds. RESULTS I. Valvular Pulmonic Stenosis In all subjects with valvular pulmonic stenosis, the maximum ejection Fig.1. A simultaneous recording of intracardiac and external phono- cardiograms with pressure tracing of main pulmonary artery in a 19-year-old male (N.S.). The intracardiac phonocardiogram indicates a localization of the maximum ejection systolic murmur in the pulmonary artery just above the pulmonic valve. Abbreviations: I-PCG=intracardiac phonocardiogram , PCG=external phonocardiogram, PA=pulmonary artery, 2L=the second left intercostal space, SM=systolic murmur, IIP=the pulmonary component of the second heart sound. Jap. HeartJ. 694 KAMBE, ET AL. November, 1976 Fig.2. A 19-year-old female with moderate pulmonic stenosis and func- tional infundibular stenosis. Note the ejection systolic murmur in the pulmo- nary artery just above the valve (upper panel), whereas a late systolic murmur is found in the outflow tract of right ventricle (lower panel). The latter is thought to be due to the functional infundibular stenosis. Abbreviations: RV=right ventricle, 3L=the third left intercostal space. Other abbreviations as in Fig.1. systolic murmur was recorded in the pulmonary artery just above the pul- monic valve, radiating from the main pulmonary trunk to the periphery of left and right pulmonary arteries. Fig.1 demonstrates an example of mild valvular stenosis (19-year-old male, N.S.). Simultaneous registration of in- tracardiac and external phonocardiograms was made together with the pres- sure tracing of the main pulmonary artery. The intracardiac phonocardio- gram (I-PCG) indicates a localization of the maximum ejection systolic murmur in the pulmonary artery just above the pulmonic valve. The interval of the second heart sound splitting amounted to 80 msec, and the pressure gradient across the pulmonic valve was 37mmHg in systole. There was no systolic murmur in the outflow tract of right ventricle. Moreover, right Vol.17 INTRACARDIAC PHONOCARDIOGRAPHY 695 No.6 Fig.3. A mode of propagation of systolic murmur from the pulmonary artery to the right atrium (upper panel) and superior vena cava (lower panel) in a 26-year-old female with valvular pulmonic stenosis associated with partial pulmonary venous return draining into left innominate vein through vertical vein. In the right atrium and superior vena cava, there are ejection systolic murmurs which are considered to be propagated from the pulmonary artery. Abbreviation: RA=right atrium, SVC=superior vena cava. Other ab- breviations as in Fig.1. ventriculography did not prove the presence of functional infundibular steno- sis. In moderate or severe valvular pulmonic stenosis, a late systolic murmur was demonstrated in the outflow tract of right ventricle, which corresponded to the findings obtainded by the selective angiocardiography of right ven- tricle. Fig.2 shows a simultaneous registration of intracavitary and external phonocardiograms with intracardiac pressure in a 19-year-old female with moderate valvular pulmonic stenosis and functional infundibular stenosis (Y.S.). The diagnosis was corroborated by open heart surgery, and the systolic pressure gradient across the pulmonic valve was found to be 80mmHg. The intracardiac phonocardiogram revealed that the largest ejection systolic murmur was just above the pulmonic valve, whereas a late systolic murmur Jap. Heart J. 696 KAMBE, ET AL. November, 1976 was found in the outflow tract of right ventricle. The latter can be attributed to a functional infundibular stenosis. In valvular pulmonic stenosis with or without associated heart anomalies, an ejection systolic murmur was also recorded in the superior vena cava in 15 out of 19 cases, and in the right atrium in 18 out of 25 patients. This phenomenon is explained by a transmission from the pulmonary artery, due to their close relationship. Fig.3 illustrates a mode of propagation of systolic murmur from the pulmonary
Recommended publications
  • Cardiac Amyloidosis and Surgery. What Do We Know About Rare
    Cardiac amyloidosis and surgery. What do we know about rare diseases? Carlos Mestres1 and Mathias van Hemelrijck2 1University Hospital Zurich 2UniversitatsSpital Zurich May 3, 2021 Commentary to JOCS-2020-RA-1888 JOCS-2020-RA-1888 Cardiac amyloidosis in non-transplant cardiac surgery Cardiac amyloidosis and surgery. What do we know about rare diseases? Running Title: Cardiac amyloidosis and cardiac surgery Carlos { A. Mestres MD PhD FETCS1, 2, Mathias Van Hemelrijck MD1 1 - Clinic of Cardiac Surgery, University Hospital Zurich,¨ Zurich¨ (Switzerland) 2 - Department of Cardiothoracic Surgery, The University of the Free State, Bloemfontein, (South Africa) Word count (All): 1173 Word count (Text): 774 Key words : Cardiac amyloidosis, cardiac surgery, rare disease Correspondence: Carlos A. Mestres, MD, PhD, FETCS Clinic for Cardiac Surgery University Hospital Zurich,¨ R¨amistrasse 100 CH 8091 Zurich¨ (Switzerland) Email: [email protected] Rare diseases are serious, chronic and potentialy lethal. The European Union (EU) definition of a rare disease is one that affects fewer than 5 in 10,000 people (1). In the EU, these rare diseases are estimated to affect up to 8% of the roughly 500 million population (2). In the United States, a rare disease is defined as a condition affecting fewer than 200,000 people in the US (3). This a definition created by Congress in the Orphan Drug Act of 1983 (4). Therefore, the estimates for the US are that 25-30 million people are affected by a rare disease. There are more than 6000 rare diseases and 80% are genetic disorders diagnosed during childhood. Despite all community efforts, there are still a lack of an universal definition of rare diseases.
    [Show full text]
  • Heart Valve Disease: Mitral and Tricuspid Valves
    Heart Valve Disease: Mitral and Tricuspid Valves Heart anatomy The heart has two sides, separated by an inner wall called the septum. The right side of the heart pumps blood to the lungs to pick up oxygen. The left side of the heart receives the oxygen- rich blood from the lungs and pumps it to the body. The heart has four chambers and four valves that regulate blood flow. The upper chambers are called the left and right atria, and the lower chambers are called the left and right ventricles. The mitral valve is located on the left side of the heart, between the left atrium and the left ventricle. This valve has two leaflets that allow blood to flow from the lungs to the heart. The tricuspid valve is located on the right side of the heart, between the right atrium and the right ventricle. This valve has three leaflets and its function is to Cardiac Surgery-MATRIx Program -1- prevent blood from leaking back into the right atrium. What is heart valve disease? In heart valve disease, one or more of the valves in your heart does not open or close properly. Heart valve problems may include: • Regurgitation (also called insufficiency)- In this condition, the valve leaflets don't close properly, causing blood to leak backward in your heart. • Stenosis- In valve stenosis, your valve leaflets become thick or stiff, and do not open wide enough. This reduces blood flow through the valve. Blausen.com staff-Own work, CC BY 3.0 Mitral valve disease The most common problems affecting the mitral valve are the inability for the valve to completely open (stenosis) or close (regurgitation).
    [Show full text]
  • Tetralogy of Fallot: Stroke in a Young Patient
    Open Access Case Report DOI: 10.7759/cureus.2714 Tetralogy of Fallot: Stroke in a Young Patient Hassam Ali 1 , Shiza Sarfraz 2 , Muhammad Sanan 1 1. Medical 4, Bahawal Victoria Hospital, Quaid-E-Azam Medical College, Bahawalpur, PAK 2. Department of Anesthesiology, Bahawal Victoria Hospital, Quaid-E-Azam Medical College, Bahawalpur, PAK Corresponding author: Hassam Ali, [email protected] Abstract Tetralogy of Fallot (TOF) is a congenital birth defect of the heart which actually comprises four individual flaws. It causes poor flow of oxygenated blood to the organs and leads to cyanosis (blue-tinted skin, because of inadequate oxygenation). It can be recognized at birth or in adulthood. But sometimes, cases may go unnoticed, and the patient might present with some rare complications. In this case, the patient presented with an embolic infarct of the brain at the age of 25 with an undiagnosed tetralogy of Fallot. Categories: Cardiology, Internal Medicine, Neurology Keywords: congenital heart defects, embolic stroke, tetralogy of fallot, paralysis, cardiology, cerebrovascular accident, heart, neurology, international medicine Introduction Tetralogy of Fallot (TOF) is a heart disease present at birth [1]. It consists of four defects [2]: - Pulmonary stenosis - Ventricular septal defect - Right ventricular hypertrophy - Aorta overriding the ventricular septal defect Some babies, when they cry or breastfeed, may turn very blue. This is because of "a tet spell" due to the shunting of excess deoxygenated blood from the right chamber of the heart to the left chamber. Such babies may have difficulty breathing, become limp, or even lose consciousness [3]. TOF is treated by open-heart surgery, mostly in the first year of life.
    [Show full text]
  • Trilogy of Fallot in a Dog
    J Vet Clin 29(5) : 404-407 (2012) Trilogy of Fallot in a Dog Ran Choi, Hyo-Jin Ahn and Changbaig Hyun1 Section of Small Animal Internal Medicine, College of Veterinary Medicine, Kangwon National University, Chuncheon 201-100, Korea (Accepted: October 05, 2012) Abstract : A 3 years-old female mixed dog (weighing 5.3 kg) was referred to veterinary teaching hospital of Kangwon National University with primary complaints of syncope, severe exercise intolerance, depression and lethargy. Diagnostic studies revealed polycythemia, right sided cardiac enlargement on thoracic radiography and right-to left atrial septal defect, severe pulmonary stenosis (~5 m/s of peak velocity) and right ventricular hypertrophy. Based on diagnostic findings, the dog was diagnosed as trilogy of Fallot. To improve clinical condition of this dog, diltiazem and enalapril were prescribed with weekly phlebotomy. To author’s best knowledge, this is the first case of trilogy of Fallot in Korea. Key words : trilogy of Fallot, atrial septal defects, pulmonic stenosis, right ventricular hypertrophy, CHD. Introduction ring veterinarian, the dog had history of cardiac murmur after birth and occasional syncopal episodes (increasing frequency Trilogy of Fallot is a compound congenital heart defects recently). On the physical examination, the dog had grade 2/6 (CHD) comprised of pulmonary stenosis, atrial septal dys- mild systolic murmur at right apex and left base of heart. The morphogenesis (e.g. atrial septal defect and patent foramen systolic blood pressure measured by Doppler method was ovale) and right ventricular hypertrophy (1). The CHD are 100-110 mmHg. broadly classified into cyanotic CHD and non-cyanotic CHD.
    [Show full text]
  • Cardiac Surgery a Guide for Patients and Their Families Welcome to the Johns Hopkins Hospital
    HEART AND VASCULAR INSTITUTE Cardiac Surgery A guide for patients and their families Welcome to The Johns Hopkins Hospital We are providing this book to you and your family to guide you through your surgical experience at the Johns Hopkins Heart and Vascular Institute. The physicians, nurses and other health care team members strive to provide you with the safest and best medical care possible. Please do not hesitate to ask your surgeon, nurse or other health care team member any questions before, during and after your operation. The booklet consists of two major sections. The first section informs you about the surgery and preparing for the hospital stay. The second section prepares you for the recovery period after surgery in the hospital and at home. TABLE OF CONTENTS Welcome to Johns Hopkins Cardiac Surgery 1 The Function of the Heart 2 Who’s Taking Care of You 3 Heart Surgery 4 Preparation for Surgery 5 Preoperative Testing and Surgical Consultation 7 The Morning of Surgery 9 After Surgery 10 Going Home After Cardiac Surgery 19 How We Help with Appointments and 24 Other Arrangements for Out-of-Town Patients Appendix 25 Looking back, it was the choice of my life. It’s not easy to put your heart in someone else’s hands. But for me, the choice was clear: I trusted it to Hopkins. My Heart. My Choice Patient Lou Grasmick, Founder & CEO, Louis J. Grasmick Lumber Company, Inc. Welcome to Johns Hopkins Cardiac Surgery The Johns Hopkins Hospital has a distinguished history of advancements in the treat- ment of cardiovascular diseases in adults and children, beginning with the Blalock-Taussig shunt in 1944.
    [Show full text]
  • Cover Title Is Vesta Std Regular 48/52 with 45Pt After. 2020 Facility And
    2020 Facility and Physician Cover title is Vesta Billing Guide Std Regular 48/52 Surgicalwith Heart Valve45pt Therapy after. Cover subtitle is Vesta Std Regular 18/22. Surgical Valve Repair and Replacement Procedures Physician Billing Codes Clinicians use Current Procedural Terminology (CPT)1 codes to bill for procedures and services. Each CPT code is assigned unique Relative Value Units (RVUs), which are used to determine payment by the Centers for Medicare & Medicaid Services (CMS) and other payers. Some commonly billed CPT codes used to describe procedures related to Edwards Lifesciences’ Heart Valve technologies are listed below.2 This list may not be comprehensive or complete. These procedures may be subject to the CMS multiple procedure reduction rule. When applicable, a payment reduction of 50% is applied to all payment amounts except the procedure with the greatest RVUs, which is paid at 100% unless exempt by CPT instructions or payer policy. Medicare National Average CPT Code Description Physician Payment3 Facility Setting Aortic 33390 Valvuloplasty, aortic valve, open, with cardiopulmonary bypass; simple $2,018 (ie, valvotomy, debridement, debulking, and/or simple commissural resuspension) 33391 Valvuloplasty, aortic valve, open, with cardiopulmonary bypass; complex $2,398 (eg, leaflet extension, leaflet resection, leaflet reconstruction, or annuloplasty) 33405 Replacement, aortic valve, open, with cardiopulmonary bypass; with prosthetic valve other $2,373 than homograft or stentless valve 33406 Replacement, aortic valve, open,
    [Show full text]
  • BPA-ICD9 Diagnosis Code Listing Alphabetical Order WA Register of Developmental Anomalies
    BPA-ICD9 Diagnosis Code Listing Alphabetical Order WA Register of Developmental Anomalies Description Code Major 17 ALPHA HYDROXYLASE DEF SYNTH25524 Y ANTERIOR EYE ANOMALY OTHER74348 Y 21 HYDROXYLASE DEF SYNTHESIS25520 Y ANUS ECTOPIC/ANTERIORLY PLACED75153 Y 47,XXX 75885 Y ANUS/INTEST/CYST DUPLICATION75150 Y 47,XYY 75884 Y AORTA ANOMALY OTHER SPEC74728 Y ABNORMAL LIMB UNSPECIFIED75548 Y AORTA ANOMALY UNSPECIFIED74729 Y ABSENCE DIGITS UNSPECIFIED75544 Y AORTA OVERRIDING 74726 Y ABSENCE OF BRAIN 74000 Y AORTIC ARCH INTERRUPTED 74712 Y ABSENT NIPPLE 75763 N AORTIC ARCH R SIDED 74723 Y ACCESSORY AURICLE/S 74410 N AORTIC ATRESIA 74720 Y ACCESSORY DIGIT/S UNSPECIFIED75509 N AORTIC HYPOPLASIA 74721 Y ACCESSORY FINGER/S 75500 N AORTIC ROOT DILATATION 74727 Y ACCESSORY HAND/FOREARM 75504 Y AORTIC STENOSIS SUPRA 74722 Y ACCESSORY THUMB/S 75501 N AORTIC VALVE BICUSPID 74640 Y ACCESSORY TOE/S 75502 N AORTIC VALVE DYSPLASIA 74631 Y ACHILLES TENDON/S SHORT 75472 Y AORTIC VALVE STENOSIS 74630 Y ACHONDROPLASIA 75643 Y AORTOPULMONARY WINDOW 74501 Y ACRANIA 74001 Y APHAKIA 74330 Y ADDISONS DISEASE 25540 Y ARGINOSUCCINIC ACID DEFICIENCY27060 Y ADENOMA LIVER 21150 Y ARM ANOMALIES OTHER SPECIFIED75556 Y ADENOMYOMA GASTRIC PYLORIS21100 Y ARM/S ABSENT (HAND PRESENT)75521 Y ADRENAL ANOMALY OTHER 75918 Y ARM/S ABSENT (NO HAND) 75520 Y ADRENAL GLAND ABSENT 75910 Y ARM/SHOULDER ANOM OTHER SPEC75558 Y ADRENAL GLAND ANOMALY UNSPEC75919 Y ARM/SHOULDER ANOM UNSPECIFIED75559 N ADRENAL GLAND ECTOPIC 75913 N ARNOLD CHIARI MALF NO SPIN BIF74227 Y ADRENAL HYPERPL CONG NO
    [Show full text]
  • Anaesthesia for Cardiac Surgery Most Adult Heart Surgery in Australia and New Zealand Is Performed for Coronary Artery Disease and Heart Valve Disease
    Anaesthesia for cardiac surgery Most adult heart surgery in Australia and New Zealand is performed for coronary artery disease and heart valve disease. Cardiac surgery is done under general anaesthesia, which means the patient is in a state of carefully controlled, medication-induced unconsciousness and will not respond to pain. It includes changes in breathing and circulation. In most cases, patients are admitted to hospital the day before surgery and undergo relevant investigations, such as blood tests and x-rays. Before the operation It is important that you speak to your doctor about whether you should stop eating and drinking before your anaesthetic. The anaesthetist will also need information such as: • Any recent coughs, colds or fevers. • Any previous anaesthetics or family problems with anaesthesia. • Abnormal reactions or allergies to drugs. • Any history of asthma, bronchitis, heart problems or other medical problems. • Any medications you may be taking. What to expect On the morning of the operation, patients may be given a “pre-med”, or medication to reduce anxiety; however, they will be conscious when they arrive at the operating theatre complex. All valve surgery and most coronary bypass surgery is performed on a non-beating heart. Because the body requires oxygen, which is carried by circulating blood, a machine temporarily takes over the function of the lungs and the heart to pump blood around the body. This machine is called a heart- lung machine or cardiopulmonary bypass machine. Specialist anaesthetists and cardiac perfusionists may work together to manage this machine during the operation. Some coronary artery bypass surgery is done without cardiopulmonary bypass.
    [Show full text]
  • BPA-ICD9 Diagnosis Code Listing Numerical Order WA Register for Developmental Anomalies
    BPA-ICD9 Diagnosis Code Listing Numerical Order WA Register for Developmental Anomalies Code Major Description 09090 Y SYPHILIS CONGENITAL 25330 Y GROWTH HORMONE DEFICIENCY 16200 Y RHABDOMYOSARCOMA LUNG 25331 Y PITUITARY DWARFISM OTHER 17100 Y FIBROSARCOMA CONGENITAL 25342 Y PITUITARY HORMONE DEFICIENCY 17190 Y MALIG NEOPLASM CONNECTIVE TISS 25351 Y DIABETES INSIPIDUS NOS 17300 Y GORLIN SYNDROME 25511 Y BARTTER SYNDROME 18690 Y ORCHIOBLASTOMA 25520 Y 21 HYDROXYLASE DEF SYNTHESIS 18900 Y RHABDOMYOSARCOMA BLADDER 25524 Y 17 ALPHA HYDROXYLASE DEF SYNTH 19050 Y RETINOBLASTOMA 25525 Y ADRENAL HYPERPL CONG SALT LOSS 19051 Y GLIOMA OPTIC NERVE 25526 Y ADRENAL HYPERPL CONG NO SALT L 19100 Y MALIG NEOPLASM BRAIN 25529 Y ADRENOGENTIAL DIS OTHER&UNSPEC 19400 Y MALIG NEOPLASM ENDOCRINE GLAND 25540 Y ADDISONS DISEASE 19410 Y NEUROBLASTOMA 25543 Y PSEUDO HYPOALDOSTERONISM 19500 Y GLIOMA NASAL 25548 Y FAMILIAL ACTH (GLUCOID DEF) 20250 Y LETTERER-SIWE DISEASE 25549 Y CORTICOADRENAL INSUFF UNSPEC 20290 Y HAEMOPHAGOCYTIC LYMPHOHISTIOCY 25910 Y PRECOCIOUS PUBERTY 20400 Y LEUKAEMIA LYMPHOBLASTIC CONG 25980 Y PROGEROID SYNDROME 20500 Y LEUKAEMIA MYELOID CONG 25981 Y SOTOS SYN/CEREBRAL GIGANTISM 20600 Y LEUKAEMIA MONOCYTIC ACUTE CONG 26800 Y RICKETTS CONG 20890 Y LEUKAEMIA CONGENITAL NOS 27000 Y CYSTINOSIS 21000 Y MYOFIBROMA TONGUE 27001 Y CYSTINURIA 21100 Y ADENOMYOMA GASTRIC PYLORIS 27002 Y FANCONI SYNDROME 21150 Y ADENOMA LIVER 27003 Y HARTNUP DISEASE 21270 Y RHABDOMYOMA HEART 27009 Y AMINO-ACID TRNSPT DISTRB OTHER 21300 Y OSTEOCHONDROMATA 27010 Y PKU 21400
    [Show full text]
  • The Clinical Evolution of Shunt-Operations for Morbus Caeruleus: Results of 150 Operations, in a Long-Term Follow-Up
    The Clinical Evolution of Shunt-Operations for Morbus Caeruleus: Results of 150 Operations, in a Long-Term Follow-Up C. A. Mahuim, M.D., C.L.C. van Nieuwenhuizen, M.D., H.A.H. D’heer, M.D., and F. Sloojj, M.D., Utrecht, Netherlands INTRODUCTION The classical operations of Blalock,4 Potts,25 and Brocks which have been used for more than 10 years in treating the tetralogy of Fallot are purely symp- tomatic. Their aim is to augment the pulmonary circulation in order to increase the oxygenation of the blood. However, they do not, properly speaking, correct the malformation. In fact, with the procedures of Blalock and Potts a fifth malformation is created in a heart that already has four. It is well known that an operation which creates an artificial ductus arteriosus must, in the long run, produce a significant overloading of the heart. In any event, the immediate benefits of the operation, in so far as the general status of the patients and the amelioration of the cyanosis are concerned, are so evident that the undeniable usefulness of this type of operation is universally recognized. TABLE I GOOD AUTHOR AND NUMBER PROCEDURE USED (IN OVER-ALL I UZSULTS YEAR OF ORDEROFFREQUENCY) MORTALITY (PER FOLLOW-UP PATIENTS (PER CENT) CENT) -- Potts, 1956 514 Potts 9 ? ? Johnson, 1951 144 Blalock, Potts 12 ? ? Bret, 1952 172 Potts, Blalock, Brock 20 i Derra, 1952 242 Blalock. Brock 19 7’: ? Dubost, 1954 333 Blalock; Potts, Brock 16 78 ? Brock, 1955 140 Brock 11.5 ? Sellers, 1950 Blalock, Potts, Brock 10.5 E.5 6 mo.
    [Show full text]
  • Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 77, NO. 6, 2021 ª 2021 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION PUBLISHED BY ELSEVIER Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation a, b, a a Philippe B. Bertrand, MD, PHD, * Jessica R. Overbey, DRPH, * Xin Zeng, MD, PHD, Robert A. Levine, MD, c d e f b Gorav Ailawadi, MD, Michael A. Acker, MD, Peter K. Smith, MD, Vinod H. Thourani, MD, Emilia Bagiella, PHD, Marissa A. Miller, DVM, MPH,g Lopa Gupta, MPH,b Michael J. Mack, MD,h A. Marc Gillinov, MD,i b b b j Gennaro Giustino, MD, Alan J. Moskowitz, MD, Annetine C. Gelijns, PHD, Michael E. Bowdish, MD, Patrick T. O’Gara, MD,k James S. Gammie, MD,l Judy Hung, MD,a on behalf of the Cardiothoracic Surgical Trials Network (CTSN) ABSTRACT BACKGROUND Whether to repair nonsevere tricuspid regurgitation (TR) during surgery for ischemic mitral valve regurgitation (IMR) remains uncertain. OBJECTIVES The goal of this study was to investigate the incidence, predictors, and clinical significance of TR pro- gression and presence of $moderate TR after IMR surgery. METHODS Patients (n ¼ 492) with untreated nonsevere TR within 2 prospectively randomized IMR trials were included. Key outcomes were TR progression (either progression by $2 grades, surgery for TR, or severe TR at 2 years) and presence of $moderate TR at 2 years. RESULTS Patients’ mean age was 66 Æ 10 years (67% male), and TR distribution was 60% #trace, 31% mild, and 9% moderate. Among 2-year survivors, TR progression occurred in 20 (6%) of 325 patients.
    [Show full text]
  • Cardiac Surgery Was Performed Under Beating Heart
    This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues. Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited. In most cases authors are permitted to post their version of the article (e.g. in Word or Tex form) to their personal website or institutional repository. Authors requiring further information regarding Elsevier’s archiving and manuscript policies are encouraged to visit: http://www.elsevier.com/copyright Author's personal copy Review REVIEW On-pump Beating Heart Surgery Ansheng Mo, MD a,∗ and Hui Lin, MD a,b a Department of Cardiothoracic Surgery, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China b The People’s Hospital of Wuhan University, Wuhan, China On-pump beating heart surgery has been proposed as a superior technique for cardiac surgery, and is receiving renewed interest from cardiac surgeons. Here, we review the technique, focusing on the basic principles of myocardial protection, operative methodology, category, intraoperative concerns, current status, organ protection, advantages, disadvantages, indications, contraindications, unanswered questions, and future research. (Heart, Lung and Circulation 2011;20:295–304) © 2011 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier Inc. All rights reserved. Keywords. On-pump; Beating heart; Ischaemia–reperfusion Introduction Feasibility of Surgery on the Empty Beating Heart ardiac surgery was performed under beating heart Myocardial Protection C or ventricular fibrillation conditions prior to the During on-pump beating heart surgery, the oxygen advent of cardioplegia, which made surgery easier.
    [Show full text]